A new SelectScience application compendium, produced in partnership with Sartorius, provides important solutions for the effective discovery and development of therapeutic monoclonal antibodies for cancer.
Antibody-based therapeutics represent an important advancement in the fight against cancer. With treatment options already available for several cancer types, therapeutic monoclonal antibodies now offer one of the most successful therapeutic strategies for both hematologic cancers and solid tumors in recent years.
This new resource highlights the advantages of cutting-edge technologies and equipment, such as the Intellicyt® iQue Screener PLUS from Sartorius, and how these methods enable rapid identification and characterization of candidate molecules with superior target reactivity and optimized functionality.
Explore the latest solutions in the development of monoclonal antibodies for cancer therapies: